Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1972 1
1974 1
1979 1
1984 1
1992 1
1993 2
1995 3
1998 1
2000 1
2001 1
2002 3
2003 4
2005 1
2007 1
2008 2
2009 1
2010 2
2011 4
2012 1
2014 4
2015 2
2016 5
2017 4
2018 1
2019 7
2020 2
2021 4
2022 10
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Bacteriophages.
Kasman LM, Porter LD. Kasman LM, et al. 2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29630237 Free Books & Documents.
Tuberin levels during cellular differentiation in brain development.
Fidalgo da Silva E, Abu Khatir B, Drouillard C, Hinch I, Davis GO, Sameem M, Patel R, Fong J, Lubanska D, Porter LA. Fidalgo da Silva E, et al. Among authors: porter la. Differentiation. 2023 Mar-Apr;130:43-50. doi: 10.1016/j.diff.2022.12.004. Epub 2022 Dec 24. Differentiation. 2023. PMID: 36608575
Atypical cell cycle control over neural cell fate.
Lubanska D, Porter LA. Lubanska D, et al. Among authors: porter la. Cell Cycle. 2014;13(19):2987. doi: 10.4161/15384101.2014.962849. Cell Cycle. 2014. PMID: 25486555 Free PMC article. No abstract available.
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.
Hamm C, Fifield BA, Kay A, Kulkarni S, Gupta R, Mathews J, Ferraiuolo RM, Al-Wahsh H, Mailloux E, Hussein A, Porter LA. Hamm C, et al. Among authors: porter la. Med Oncol. 2022 Feb 1;39(4):49. doi: 10.1007/s12032-021-01637-0. Med Oncol. 2022. PMID: 35103812 Clinical Trial.
71 results